PRDM1 抗体 (full length)
Our Local Distributor
北京 101111
Quick Overview for PRDM1 抗体 (full length) (ABIN7878834)
抗原
See all PRDM1 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- full length
-
原理
- BLIMP-1 Antibody / PRDM1
-
纯化方法
- Protein A/G affinity
-
免疫原
- Recombinant full-length human protein was used as the immunogen for the BLIMP-1 antibody.
-
亚型
- IgG2a
-
-
-
-
应用备注
- Optimal dilution of the BLIMP-1 antibody should be determined by the researcher.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.2 mg/mL
-
缓冲液
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Aliquot the BLIMP-1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- PRDM1 (PR Domain Containing 1, with ZNF Domain (PRDM1))
-
别名
- BLIMP-1
-
背景
- The development and differentiation of plasma cells, which are terminally differentiated B-cells, are induced by Blimp-1 (B lymphocyte-induced maturation protein, also designated PRDI-BF1). Blimp-1 is a transcriptional repressor that localizes to the nucleus and is considered a master regulator of terminal B-cell development. Alone, Blimp-1 is sufficient to trigger terminal B-cell differentiation. Blimp-1 upregulates the expression of syndecan-1 and J chain, represses IFN-b gene transcription and associates with HDAC to recruit it to DNA, thereby repressing c-Myc. Blimp-1 is expressed during the late stages of B-cell differentiation in immunoglobulin-secreting plasma cells, as well as in long-lived, bone marrow plasma cells. The expression of Blimp-1 defines a checkpoint beyond which fully activated B cells proceed to the plasma cell stage, whereas immature and partially activated cells are eliminated.
-
UniProt
- O75626
-
途径
- Regulation of Muscle Cell Differentiation
抗原
-